Study Shows Correlation Between Multiple Sclerosis Risk and Low Vitamin D Levels
An international team led by researchers at McGill University in Canada recently published in the journal PLOS…
Articles by Patricia Silva, PhD
Clinical Studies of Cannabinoid Capsules for MS Expected Later This Year
Multiple sclerosis (MS) is a disease characterized by the destruction of insulating covers on nerve cells by the immune system.
Decreased Activity Levels in MS Patients Linked To Cognitive Impairment
A new study published in the American Journal of Occupational Therapy assessed the cognitive factors affected in…
Novartis Acquires Remaining Rights to Ofatumumab by GSK for Multiple Sclerosis and Other Autoimmune Diseases
Pharmaceutical giant Novartis recently announced it has signed an agreement with GlaxoSmithKline for exclusive rights to GSK’s investigational CD20-specific monoclonal…
Omnicare Donates $100,000 to National MS Society’s NOW Campaign for Research and Fellowships
Omnicare, a Fortune 500 company based in Cincinnati, Ohio that provides comprehensive pharmaceutical services to patients and providers across the United States,…
Pediatric MS Patients Can Benefit Greatly from Strenuous Physical Activity, Study Suggests
A recently published study in the journal Neurology entitled “lower physical activity is associated with higher…
Oral Disease Modifying Agents for Multiple Sclerosis Are Now More Preferred by Neurologists
A survey of 97 neurologists conducted in June 2015 revealed specialists within the field of neurology are increasingly avoiding prescribing injectables…
Chicago Local Erica Montelo Named MuckFest MS’ 100,000th Participant
Every year, the National Multiple Sclerosis Society hosts MuckFest MS, a fun mud and obstacle 5K event that raises funds…
Vitae Pharmaceuticals to Launch New Study of Therapy For MS, Other Autoimmune Disorders
Clinical stage biotech company Vitae Pharmaceuticals, Inc., recently announced the launch of a Phase I multiple ascending dose clinical study of…
New MS Testing Model Can Predict If Disease Will Intensify in Patients
A new study published in the journal Statistical Methods in Medical Research revealed a new method to…
Cases of Brain Infection Reported in MS Patients Taking Gilenya
Multiple sclerosis patients prescribed Gilenya (fingolimod) are now being informed about a handful of documented cases where the therapy was…
Pfizer Acquires Exclusive Commercialization Rights to Generic Copaxone for Relapsing Remitting Multiple Sclerosis
Netherlands-based international pharmaceutical company Synthon, best known for developing complex generic therapeutics, has officially entered into an agreement with pharmaceutical…
MS Views and News Announces August Educational Events
The non-profit organization MS News and Views (MSVN) announced that it will host four educational events during the month…
MS Study Uses Findings on Quality of Life Issues To Develop New Confidence-Building Intervention
The major challenge patients with multiple sclerosis face is nearly constant muscle weakness and fatigue caused by progressive nerve and…
NHS Wales Approves Biogen’s Plegridy for Relapsing Remitting MS
Relapsing remitting multiple sclerosis (RRMS) treatment Plegridy (peg interferon beta-1a) by Biogen Idec, has just received Welsh NHS approval, which should…
Nutra Pharma Working on Pediatric MS Treatment Based on Venom
Nutra Pharma, a US-based biotechnology a company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for…
Study Evaluates Gilenya’s Impact on Central Autonomic Dysfunction In MS With Delayed Heart Rate
Fingolimod, also known by its brand name Gilenya, is an oral immunotherapy approved for the treatment of relapsing-remitting multiple sclerosis…
Study on French MS Population Reveals Long Disease Duration is Associated with Higher Mortality
A study recently published in the journal PLoS One revealed an excess mortality rate among French patients…
Study Finds Physical Activity and Exercise Have Considerable Health Benefits for MS Patients
In a recent study published in the International Journal of Molecular Sciences, a team of researchers from…
New MS Study Shows TYSABRI Improves Cognitive Impairment
Researchers at Spedali Civili of Brescia in Italy recently published findings in the journal PLoS One that Biogen’s…
Researchers Offer New Insights into Cognitive Deficits in Multiple Sclerosis Patients
A new study led by researchers at the Center for BrainHealth at the University of Texas at Dallas and…
National MS Society Awards WSU Professor With Grant to Develop New MS Research Model
Alexander Gow, Ph.D., a professor at the Wayne State University School of Medicine, has just been awarded a research grant…
Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients
Roche recently announced encouraging results on its investigational medicine ocrelizumab as a therapy for patients with relapsing multiple sclerosis,…
“MS” Documentary Released on YouTube
“MS” is a documentary film released last year that tells the story of three patients who suffer from…
MS Views and News Seeks to Improve MS Education in July
MS Views and News (MSVN) is a non-profit organization that works at collecting, presenting and distributing information about multiple…
Novartis’ Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis
A new study recently published in the Journal of Neurology, Neurosurgery and Psychiatry revealed that long-term fingolimod…
Researchers Offer New Insights into the Link Between Multiple Sclerosis and Specific Autoantibodies
Researchers at Immco Diagnostics and the State University of New York in Buffalo recently reported in the journal…
MedDay Reveals Promising Data on Progressive Multiple Sclerosis Therapy
MedDay, a biotechnology company dedicated to developing therapies for nervous system disorders, recently announced encouraging data on its pivotal…
Canadian Drug Expert Committee Recommends MS Therapy LEMTRADA For Public Coverage
The Canadian Drug Expert Committee (CDEC) recently recommended that LEMTRADA (alemtuzumab) be included in provincial and other public drug plans for the…
Study Shows Vitamin D Supplementation in Pregnant Women With MS Positively Impacts Disease Severity
In women of childbearing age, low vitamin D levels are a common issue often resulting from low intake of vitamin…